(Q43183967)

15 November 2017

title

Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers (English)

1 reference

15 November 2017

1 reference

H-P Lei

1

1 reference

15 November 2017

X-Y Yu

2

1 reference

15 November 2017

H-T Xie

3

1 reference

15 November 2017

H-H Li

4

1 reference

15 November 2017

L Fan

5

1 reference

15 November 2017

L-L Dai

6

1 reference

15 November 2017

Y Chen

7

1 reference

15 November 2017

H-H Zhou

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

40

1 reference

15 November 2017

issue

4

1 reference

15 November 2017

page(s)

275-281

1 reference

Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St. John's wort: role of active compounds for its mechanism of action and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Bupropion: pharmacology and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Effect of St John's wort on imatinib mesylate pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Herb-drug interactions: review and assessment of report reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

The interaction between St John's wort and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Bupropion: a review of its use in the management of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Pharmacokinetic interactions between herbal remedies and medicinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St. John's wort and oral contraceptives: reasons for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Dietary supplements in a national survey: Prevalence of use and reports of adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St John's for depression, worts and all.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

St John's wort-associated drug interactions: short-term inhibition and long-term induction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

Role of hyperforin in the pharmacological activities of St. John's Wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903509383

10.3109/00498250903509383

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference